Nanoparticle drug delivery systems for inner ear therapy: An overview

Abstract

Local drug delivery based on nanoparticles (NP) represents a novel strategy to improve inner ear treatments. The intratympanic delivery of NP may be suitable to treat or prevent hearing loss originating from damage to hair cells and spiral ganglion neurons in the cochlea. Numerous experimental studies support in vitro and in vivo the biocompatibility of NP, their physical stability, target specificity, cell/tissue uptake and ability to internalize therapeutic agents. The topical use of NP helps to reduce the amount of drug required and avoid systemic side effects. This review focuses on recent findings and applications of different NP systems locally delivered to the inner ear. The perspectives for clinical application of NP in inner ear drug delivery are also discussed

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines

“…In the past 30 years, the nano drug system for tumor peptide vaccine has been widely studied which also reached a splendid result. First of all, it is important that the NPs allow target specificity to miminize the side effect of treatments (Delie et al., 2012 ; Valente et al., 2017 ). Secondly, some of nanoparticles are easy to be modified to express plenty of good properties like stability for a better release and absorption of drug molecule (Harms & Mueller-Goymann, 2011 ).…”

Nanoparticles for the Treatment of Inner Ear Infections

“…One of the most promising solutions is to include nanoparticles (NPs) in the therapeutic strategy [ 1 , 13 ]. Their small sizes (<1 μm) coupled with their inherent physical, chemical, and biological properties render nanoparticulate systems suitable for crossing barriers and efficiently treat inner ear infectious disorders [ 9 , 12 , 55 ].…”

“…The anatomical and physiological barriers of the ear coupled with the low long-term stability of drug molecules are the main factors that hinder drug penetration and permeation, resulting in sub-therapeutic concentrations at the required site [ 12 ]. To overcome the issues of conventional drug-administration, nanotechnology is receiving increasing attention in the field of auditory science [ 13 ]. Particularly, nanoparticle-based systems have been proven advantageous in controlled and targeted drug-release, protecting pharmacological formulations up to the desired site, facilitating transmembrane transport, increasing cell uptake, and reducing required doses and side-effects [ 14 ].…”

pH-responsive and porous vancomycin-loaded PLGA microspheres: evidence of controlled and sustained release for localized inflammation inhibition in vitro

“…Drug delivery systems should possess the property of controlled release, which is needed to achieve effective drug levels and improve treatment effect while avoiding toxic damage to healthy tissues. [10][11][12] Drug delivery systems have been constructed using various carriers, such as liposomes, hydrogels, microparticles, and nanoparticles. [13][14][15][16][17] In controlled release drug delivery systems, one or more active ingredients play a crucial role at specic locations and period when expected.…”